Teunissen

Grey matter networks and clinical progression in subjects with predementia Alzheimer ’ s disease

P. Scheltens, F. Barkhof, A. Gouw, 2017 .

SUCLG 2 identified as both a determinator of CSF A b 1 – 42 levels and an attenuator of cognitive decline in Alzheimer ’ s disease

M. Nöthen, F. Jessen, P. Scheltens, 2014 .

Atrophy subtypes in Alzheimer ’ s disease are detectable in prodromal stage and associated with different cognitive trajectories

P. Scheltens, F. Barkhof, P. Visser, 2019 .

MRI-defined areas of microvascular obstruction ( MVO ) after acute myocardial infarction represent microvascular destruction and haemorrhage

Rossum, M. Heymans, H. Niessen, 2016 .